Patient Financial News

Subscribe to enjoy similar stories. Last year Roche, a Swiss pharmaceutical firm, published a review of the clinical trials on neurological drugs it had held between 2016 and 2021. It found that black people were under-represented in all but one.

Subscribe to enjoy similar stories. When I meet a patient with a complicated medical history, I often start by asking when they were last perfectly well. Darcie couldn’t remember ever being truly well.

Gene Hackman and his wife, Betsy Arakawa, passed away in unfortunate circumstances, leaving new questions. Gene Hackman's wife, Betsy Arakawa, died in an unexpected turn of events after a doctor said she phoned his clinic a day after she was said to have died, questioning the timeline and cause of death, as per a report. With doubts raised about her diagnosis of hantavirus and Hackman's secluded last days, the case has raised speculation regarding what really happened. A week before the death of her Oscar-winning husband, Betsy Arakawa was discovered dead on February 11 from a rare rodent illness known as hantavirus pulmonary syndrome.

Subscribe to enjoy similar stories. Pfizer had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle.

CAR T-cell therapy', the treatment involves modifying genes in one's T-cells — a type of immune cells — to help fight cancer. The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system. Researchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low and middle-income countries, patients in whom 'B-cell' tumours continue to grow following a period of remission (relapse), or do not respond to treatment (refractory), suffer from poor outcomes due to an absence of effective therapies. A type of white blood cell, B-cells are crucial to one's immune system as they produce antibodies to fight infections.

With her calm, warm demeanor, Ana has been trained to put patients at ease — like many nurses across the U.S. But unlike them, she is also available to chat 24-7, in multiple languages, from Hindi to Haitian Creole. That's because Ana isn't human, but an artificial intelligence program created by Hippocratic AI, one of a number of new companies offering ways to automate time-consuming tasks usually performed by nurses and medical assistants.

bio-enhanced curcumin, the active compound in turmeric (haldi), can effectively treat mild to moderate dry eye disease (DED), reported The Times of India. DED occurs when the eyes fail to produce enough quality tears for proper lubrication. Published in the Indian Journal of Ophthalmology, the research highlights curcumin’s positive impact on improving tear film stability, lipid layer thickness, tear meniscus height, and reducing eye redness.

Recollecting a video conversation with his friend, the Reddit user detailed, “He was standing in an orderly manner at a supermarket checkout, patiently explaining the self-service process and the systematic way people respect traffic regulations. This is the very same person who, back in India, had a habit of cutting in line at bus stops and treating traffic signals as optional. The amusing part? I was always the one trying to stop him from doing so!” The post resonated with numerous readers, sparking discussions on human adaptability. One response noted, “People conform to their surroundings. If you are in an environment where everyone adheres to protocols, you will likely do the same. However, if you find yourself in a setting where people constantly push forward without order, you either join them or risk being left behind.”

Rohit Singhania, Co Head — Equities, DSP Mutual Fund, recommends investors approach ELSS funds as regular flexi-cap investments since these funds aren't constrained by market-cap restrictions. «The three-year lock-in period can also serve as a useful behavioural hack, encouraging investors to remain patient and disciplined. Investors should shift their mindset—from viewing ELSS purely as a tax-saving tool to recognizing it as a meaningful long-term investment,» he says.

trade war has rattled Wall Street, pushing the Nasdaq into correction territory, while the S&P 500 and Dow continue to decline. The Atlanta Fed has slashed its first-quarter U.S. growth forecast from a 2.4% expansion to a 2.8% contraction, fueling recession concerns. In his latest annual letter, Buffett called Trump’s tariffs an “act of war” and warned of risks from inflation, rising rates, and global instability. Buffett, known for thriving in market turmoil, has long preached that stock prices ultimately reflect business fundamentals, not short-term sentiment.

According to New York Post, Bortner had been feeling fatigued for a year but had no reason to suspect anything serious. However, while scratching a mosquito bite near her breast, she discovered a lump. Aware of stories about dogs detecting cancer through scent, she decided to get checked. A few days later, doctors diagnosed her with stage 2B triple-negative invasive ductal carcinoma—an aggressive form of breast cancer that does not respond to common hormonal treatments. “That’s how fast and aggressive this triple-negative breast cancer is,” Bortner said. “It went from non-feel-able, non-detectable to a physical lump within three months.”

Subscribe to enjoy similar stories. Two years after she started taking Xanax, Dana Bare began having panic attacks like never before. Her memory started slipping.

Health Secretary Wes Streeting confirmed plans to slash 9,000 roles from the 15,000-strong NHS England workforce, targeting hundreds of millions in savings by merging duplicated functions like communications and strategy teams. The decision reverses a 2012 Coalition-era restructuring, drawing cautious support from figures like Jeremy Hunt, though critics warn of potential disruptions to patient care. Recent resignations of NHS England’s chief executive and medical director preceded the overhaul, signaling internal turmoil.

Dr. Reddy’s Laboratories is recalling Lot No: A1540076 of Levetiracetam 0.75% Sodium Chloride Injection, 1,000 mg/100 mL, single-dose infusion bags in the United States. The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL. Patients who are administered the mislabeled product will likely experience adverse events, as per the risk statement issued by the company. Because the infusion bag is labelled as 500 mg/100 mL but actually contains 1,000 mg/100 mL dose, the patient could receive double the dose of intravenous levetiracetam than intended which could lead to immediate and serious side effects including hypersensitivity reactions, liver injury, hematological toxicity, somnolence, fatigue, dizziness, coordination difficulties, agitation, aggression, depressed level of consciousness, respiratory depression, and coma, as per the company.

Lilavati Hospital, one of the country’s most reputed healthcare institutions, is at the centre of an explosive controversy. The Lilavati Kirtilal Mehta Medical Trust (LKMMT), which runs the hospital, has accused its former trustees of siphoning off over Rs 1,500 crore through fraudulent transactions, kickbacks, and illegal offshore deals. But it doesn’t end there. The trust has also alleged that black magic rituals were conducted within the hospital premises, with human remains discovered beneath the floor of the current trustees' office. The accusations, bizarre yet serious, have resulted in multiple FIRs and a growing legal battle.

Subscribe to enjoy similar stories. A blockbuster diabetes drug will soon be available to Indian patients at a tenth of its cost, as its patent expires. At least four Indian generics players have launched cheaper variants of the drug, which is used to treat type-2 diabetes as well as heart and kidney ailments.

Subscribe to enjoy similar stories. India recently announced a budgetary allocation of ₹3,200 crore to set up 200 Day Care Cancer Centres in all district hospitals over the next three years. This is welcome.

Subscribe to enjoy similar stories. High-quality bonds are on sale, and Pimco Income fund manager Daniel Ivascyn is loading up on them. Ivascyn isn’t just any ordinary manager, and the $180 billion Pimco Income is no ordinary bond fund.

Subscribe to enjoy similar stories. For decades, scientists have been on the hunt for an antiaging drug. Now, some say we may have already found it.

Sun Pharmaceuticals on Monday announced that it is set to acquire Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million. The transaction is expected to be completed in the second calendar quarter of 2025. Checkpoint is a Nasdaq-listed commercial-stage company focused on developing novel treatments for patients with solid tumor cancers. The company has the license from the U.S. Food & Drug Administration (FDA) for UNLOXCYT (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. Dilip Shanghvi, Chairman & Managing Director of Sun Pharma, said, “Combining UNLOXCYT, an FDAapproved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma, with Sun Pharma’s global presence means patients with cSCC may soon have access to an important, new treatment option. The acquisition further bolsters our innovative portfolio in onco-derm therapy.”

They were ready last month to start enrolling patients — veterans whose cancer had spread to other tissue and who had run out of treatment options. Then a problem arose.